GIT2 and breast cancer: Furthermore, upon inspection of some exemplars of the significantly enriched pathways (Ingenuity Pathway Analysis-based) within this theoretical dataset, we not only demonstrate specific GIT2-associated activities, e.g. ‘Actin Cytoskeleton Signaling’ [53], ‘Breast Cancer Regulation by Stathmin 1’ [11] and ‘Mitochondrial dysfunction’ [13], but also novel functions, e.g. ‘Sirtuin Signaling’ and ‘Relaxin Signaling’ (Figure 3B).